IBIO today
$0.76-$0.06 (-7.52%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourSymmetric Triangle
15 minExpanding
5 minStrong Bearish
Daily trend turns up above $1.37
Key levels
Resistance$0.98
Resistance$0.85
Support$0.70
Support$0.56
Latest news & SEC filings
EarningsiBio Posts Q1 Fiscal 2027 Earnings
SEC FilingiBio, Inc. filed a report on a major company event (Form 8-K)
EarningsiBio posts smaller first-quarter loss as revenue tops estimates
All IBIO news →About iBio
iBio develops antibody medicines for obesity and related heart and metabolic conditions, relying on artificial intelligence and machine learning to design treatments for targets that are otherwise difficult to address. Its programs include IBIO-600, a myostatin-targeting antibody in early human testing, IBIO-610, an Activin E antibody in preclinical work, and IBIO-800, a bispecific candidate. Research takes place at its laboratory in San Diego, California, and the company also holds a license to an amylin-directed antibody from AstralBio.
Based on the company's 10-K filed Aug 28, 2026.
Nasdaq · Healthcare
iBio, Inc. (IBIO)
What Is the Price Target for IBIO?
SEPT Low Target
$5.00
SEPT Mid Target
$6.00
SEPT High Target
$7.00
Analyst Consensus
$6.00
Is IBIO a Buy or Sell Right Now?
Thesis
- •Revenue growing -75.0% YoY with ACCELERATING trend — accelerating momentum.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IBIO.
Start Free Trial →Is IBIO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$5.03
27
Moat Score
NONE
4/9
Piotroski Score
-1.9
Altman Z-Score
What Is Smart Money Doing with IBIO?
Insider Signal
BUYING
4 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IBIO Growth Story
Revenue YoY
-75.0%
3yr Revenue CAGR
-62.4%
EPS Growth YoY
81.71%
FCF Growth YoY
-55.3%
Revenue Trend
ACCELERATING
Dark Pool Trades for IBIO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IBIO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:50:00 | $0.77 | 1,347 | $$1K | BUY |
| 20:32:57 | $0.78 | 5,000 | $$4K | BUY |
| 20:30:46 | $0.78 | 9,600 | $$7K | BUY |
| 19:52:31 | $0.77 | 10,000 | $$8K | SELL |
| 19:31:47 | $0.79 | 5,500 | $$4K | BUY |
5 dark pool trades shown · $$24K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for iBio, Inc. (IBIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IBIO — frequently asked questions
What is IBIO stock price today?
iBio, Inc. (IBIO) is at $0.76, down 7.52% (-$0.06) at the Nov 12, 2026 close.
Why is IBIO stock moving today?
Latest IBIO news — Nov 11, 2026: iBio Posts Q1 Fiscal 2027 Earnings · Nov 10, 2026: iBio, Inc. filed a report on a major company event (Form 8-K)
What is the IBIO price target?
The average analyst price target for IBIO is $6.00, ranging from $5 to $7, based on 2 analysts. Latest: HC Wainwright & Co. initiates on Sep 17, 2026.
What do analysts rate IBIO?
Analyst ratings for IBIO: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
Did IBIO beat earnings?
IBIO last reported on Aug 28, 2026: EPS -$0.04 vs -$0.07 expected — a beat of 42.3%.
Does IBIO pay a dividend?
IBIO does not currently pay a dividend.
What are IBIO support and resistance levels?
Support: $0.70, $0.56. Resistance: $0.85, $0.98, $1.06.
What are insiders doing with IBIO?
Insider activity: BUYING, 4 buys and 0 sells in the last 90 days.
What is the latest news on IBIO?
Nov 11, 2026: iBio Posts Q1 Fiscal 2027 Earnings · Nov 10, 2026: iBio, Inc. filed a report on a major company event (Form 8-K) · Nov 10, 2026: iBio posts smaller first-quarter loss as revenue tops estimates